Skip to content

Long Non-coding RNA HOTAIR Drives Breast Cancer Progression Through miR-3619-5p/MGAT5 Axis.

Sep 2026 · Current molecular medicine · 0 citations
Medicine

TL;DR

It is suggested that HOTAIR may drive breast cancer progression through the miR-3619-5p/MGAT5 axis and might be a potential therapeutic target for breast cancer.

Abstract

INTRODUCTION HOX Transcript Antisense Intergenic RNA (HOTAIR) is a long-noncoding RNA that plays important roles in tumorigenesis. However, the underlying molecular mechanism of HOTAIR in breast cancer is not fully understood.

Methods

In this study, high-throughput sequencing was carried out to analyze breast cancer transcriptomic changes after HOTAIR was overexpressed in MCF-7 cells. Gain- and loss-of-function assays were used to examine the effects of HOTAIR on the progression of breast cancer. A double-luciferase reporter assay was used to verify the possible correlation among HOTAIR, miR-3619-5p, and MGAT5.

Results

We found that HOTAIR was overexpressed in breast cancer tissues and was related to the prognosis of breast cancer patients. Overexpression of HOTAIR promoted the proliferation, migration, and invasion of breast cancer cells. MiR-3619-5p was downregulated, and MGAT5 was upregulated in HOTAIR-overexpressing breast cancer cells compared with the negative cells. MiR-3619-5p was verified to be the target of HOTAIR, and MGAT5 was identified as a target of miR-3619-5p. MiR-3619- 5p rescued the effect of HOTAIR on the proliferation of breast cancer cells. MGAT5 silencing inhibited the proliferation of breast cancer cells. In addition, high-throughput sequencing indicated that HOTAIR overexpression altered the whole transcriptome of breast cancer.

Discussion

Our findings suggested that HOTAIR may drive breast cancer progression through the miR-3619-5p/MGAT5 axis.

Conclusion

HOTAIR might be a potential therapeutic target for breast cancer.

View source

Similar papers

Open access Sep 2026

The H19/miR-760/BST2 regulatory axis sustains breast cancer tumorigenesis and metastasis.

The long noncoding RNA H19 has been widely attested as a promoter of breast cancer by favoring proliferation, migration, invasion, and tumor growth. In this study, we attempted to decipher molecular mechanisms underlying oncogenic activities of H19. Transcriptomic analyses revealed that H19 overexpression correlates wi...

Kekely Klouyovo, Evodie Peperstraete, Léa Mabille et al. · 0 citations

RETRACTED ARTICLE: Long noncoding RNA UCA1 targets miR-582-5p and contributes to the progression and drug resistance of bladder cancer cells through ATG7-mediated autophagy inhibition

Evidence is provided for a novel UCA1 interaction regulatory network in bladder cancer, that is, UCA1-miR-582-5p-ATG7-autophagy axis, which provides a new insight into the treatment of bladder cancer.

Jun-Feng Wu, Wei Li, Jin-Zhuo Ning et al. · 0 citations
Aug 2026

The miR-338-5p/METTL3 axis regulates m6A modification to inhibit tumor progression in triple-negative breast cancer.

This study reveals post-transcriptional regulation of METTL3 by miR-338-5p by confirming a functional miR-338-5p/METTL3/m6A axis in TNBC and targeting this distinct regulatory axis represents a promising therapeutic strategy for TNBC.

Wen-Jia Chen, Ya Xu, Yang-Zheng Lan et al. · 0 citations
Open access Aug 2026

lncRNA MALAT1 sponges miR-124-3p to upregulate PIK3C2A and drive epithelial ovarian cancer progress

Epithelial ovarian cancer (EOC) is a highly lethal malignant tumor, with a poor clinical prognosis due to its early peritoneal metastasis. However, the molecular mechanism driving this malignant spread has not been elucidated. In this study, by aggregating the post-transcriptional regulatory network mediated by long no...

Wen-Xiao Li, Xiao-Li Ma, Zhi-Hui Li et al. · 0 citations
Open access Aug 2026

LncRNA HNF1A-AS1 promotes prostate cancer progression via the miR-138-5p/KDM6B axis

Prostate cancer (PCa) is a widespread malignancy with poor prognosis in advanced stages. However, the role of long non-coding RNA (lncRNA) HNF1A-AS1 in PCa progression and its underlying mechanisms remain largely unclear. This study aims to explore the expression trends and clinical associations of HNF1A-AS1 in PCa, an...

Ting-Xuan Lv, Ke-Xiang Wang, Wei-Cai Chang et al. · 0 citations

We use cookies to run the site and, with your consent, for analytics and to show ads. See our Cookie Policy.